HSR24-154: Real-World Clinical Outcomes in Patients With Advanced/Metastatic Melanoma and Brain Metastases Treated With Pembrolizumab Monotherapy—An Analysis of the ADOReg German Skin Cancer Registry

Authors:
Ruixuan Jiang Merck & Co., Inc., Rahway, NJ, USA

Search for other papers by Ruixuan Jiang in
Current site
Google Scholar
PubMed Close
 PharmD, PhD
,
Michael Weichenthal University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

Search for other papers by Michael Weichenthal in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Cesar I. Fernandez-Lazaro IQVIA, Madrid, Spain

Search for other papers by Cesar I. Fernandez-Lazaro in
Current site
Google Scholar
PubMed Close
 PhD, MPH, PharmD
,
Anja Rudolph IQVIA, 60549 Frankfurt, Germany

Search for other papers by Anja Rudolph in
Current site
Google Scholar
PubMed Close
 MSc, PhD
,
Clemens Krepler Merck & Co., Inc., Rahway, NJ, USA

Search for other papers by Clemens Krepler in
Current site
Google Scholar
PubMed Close
 MD
,
Peter Mohr DElbe Kliniken Buxtehude, Buxtehude, Germany

Search for other papers by Peter Mohr in
Current site
Google Scholar
PubMed Close
 MD, PhD
, and
on behalf of the ADOReg investigators
Search for other papers by on behalf of the ADOReg investigators in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 22: Issue 2.5
Online Publication Date:
05 Apr 2024
DOI:
https://doi.org/10.6004/jnccn.2023.7273
Restricted access

Corresponding Author: Ruixuan Jiang, PharmD, PhD
Email: ruixuan.jiang@merck.com
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2024 by the National Comprehensive Cancer Network 2024
Article Category:
Abstract
Print Publication Date:
05 Apr 2024
Online Publication Date:
05 Apr 2024

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 981 709 80
PDF Downloads 128 0 0
EPUB Downloads 0 0 0